Sale!

COL6A1 Gene Ullrich Congenital Muscular Dystrophy Genetic Test

Original price was: $700.Current price is: $500.

-29%

The COL6A1 Gene Ullrich Congenital Muscular Dystrophy NGS Genetic DNA Test is a comprehensive genetic analysis that detects mutations in the COL6A1 gene responsible for Ullrich congenital muscular dystrophy. This advanced test utilizes next-generation sequencing technology to identify specific genetic variants that cause progressive muscle weakness, joint hypermobility, and respiratory complications. Early diagnosis through this test enables proactive management strategies and personalized treatment approaches. The test is particularly valuable for individuals showing symptoms of muscle weakness from infancy, delayed motor milestones, or family history of muscular dystrophy. Results are typically available within 3-4 weeks, providing crucial information for healthcare providers to develop targeted care plans. This specialized genetic testing is available for $500 USD, offering significant savings from the regular price of $700 USD.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

COL6A1 Gene Ullrich Congenital Muscular Dystrophy NGS Genetic DNA Test

Comprehensive Genetic Analysis for Muscular Dystrophy Diagnosis

The COL6A1 Gene Ullrich Congenital Muscular Dystrophy NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for neuromuscular disorders. This advanced testing methodology provides crucial insights into the genetic basis of Ullrich congenital muscular dystrophy, enabling early intervention and personalized treatment strategies. By examining the COL6A1 gene through next-generation sequencing technology, healthcare providers can identify specific mutations that contribute to this progressive condition.

What Does This Test Measure and Detect?

This sophisticated genetic test specifically targets the COL6A1 gene, which encodes type VI collagen—a critical component of the extracellular matrix in muscle tissue. The test utilizes next-generation sequencing (NGS) technology to:

  • Identify pathogenic variants in the COL6A1 gene
  • Detect single nucleotide variants, insertions, and deletions
  • Analyze the entire coding region and splice sites
  • Provide comprehensive mutation analysis for accurate diagnosis

Who Should Consider This Genetic Test?

This test is particularly recommended for individuals exhibiting the following symptoms or circumstances:

  • Infants and children with progressive muscle weakness from birth
  • Individuals with joint hypermobility and contractures
  • Patients showing delayed motor milestones development
  • Those with respiratory complications and muscle weakness
  • Individuals with a family history of congenital muscular dystrophy
  • Patients with suspected collagen VI-related myopathies

Significant Benefits of Genetic Testing

Undergoing the COL6A1 genetic test offers numerous advantages for patients and healthcare providers:

  • Early and Accurate Diagnosis: Provides definitive diagnosis for proper treatment planning
  • Family Planning Guidance: Enables informed reproductive decisions for affected families
  • Personalized Treatment: Facilitates targeted therapeutic interventions
  • Proactive Management: Allows early implementation of respiratory and physical therapies
  • Genetic Counseling: Provides comprehensive family risk assessment

Understanding Your Test Results

Our genetic specialists provide detailed interpretation of your test results, including:

  • Positive Result: Indicates the presence of pathogenic variants in the COL6A1 gene, confirming diagnosis of Ullrich congenital muscular dystrophy
  • Negative Result: Suggests no disease-causing variants were detected in the COL6A1 gene
  • Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications requiring further evaluation
  • Carrier Status: Determines if an individual carries one copy of a mutated gene

Test Pricing Information

Price Type Amount (USD)
Discount Price $500
Regular Price $700

Test Specifications

  • Turnaround Time: 3 to 4 Weeks
  • Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
  • Methodology: Next-Generation Sequencing (NGS) Technology
  • Specialty: Neurology and Genetics
  • Disease Category: Neurological Disorders

Pre-Test Requirements

Before undergoing testing, patients should provide:

  • Complete clinical history of the patient
  • Participation in genetic counseling session
  • Detailed pedigree chart of affected family members
  • Comprehensive medical documentation

Nationwide Testing Availability

GGC DNA provides comprehensive genetic testing services across the United States, with convenient locations in major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure accurate and reliable results for patients nationwide.

Take Control of Your Health Today

Don’t let uncertainty about genetic conditions affect your quality of life. Early diagnosis through the COL6A1 Gene Ullrich Congenital Muscular Dystrophy NGS Genetic DNA Test can provide the clarity needed for effective management and treatment planning. Our team of genetic specialists and neurologists are ready to support you through every step of the testing process.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take the first step toward definitive diagnosis and personalized care.